Testosterone Replacement Therapy in Men With Sexual Dysfunction

KENTO SONODA, MD, AAHIVS,

Saint Louis University, Saint Louis, Missouri

American Family Physician. 2024;110(5):464-465.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

1.Lee H, Hwang EC, Oh CK, et al. Testosterone replacement in men with sexual dysfunction. Cochrane Database Syst Rev. 2024(1):CD013071.
2.McCabe MP, Sharlip ID, Lewis R, et al. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med. 2016;13(2):144-152.
3.Goldstein I, Goren A, Li VW, et al. The association of erectile dysfunction with productivity and absenteeism in eight countries globally. Int J Clin Pract. 2019;73(11):e13384.
4.McCabe MP, Althof SE. A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man’s inability to have sex?. J Sex Med. 2014;11(2):347-363.
5.U.S. Food and Drug Administration. Testosterone information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/testosterone-information
6.Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432.
7.Jasuja GK, Bhasin S, Rose AJ. Patterns of testosterone prescription overuse. Curr Opin Endocrinol Diabetes Obes. 2017;24(3):240-245.

These are summaries of reviews from the Cochrane Library.

This series is coordinated by Corey D. Fogleman, MD, assistant medical editor.

A collection of Cochrane for Clinicians published in AFP is available at https://www.aafp.org/afp/cochrane.

My account